InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Miller Langdon L, Directeur Médical. Director active across 1 company, notably Cleveland Biolabs INC. In total, 2 disclosures have been published. Activity tracked since 22 July 2021. The latest transaction was filed on 22 July 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
10,000 shares@ US$3.0050.0% of flowCommon Stock, par value $0.005 per shareSEC:0001437749-21-017452
10,000 shares@ US$3.0050.0% of flowCommon Stock, par value $0.005 per shareSEC:0001437749-21-017452:0
2 of 2 declarations
About Miller Langdon L
Langdon L. Miller serves as Chief Medical Officer at Cleveland Biolabs Inc. In this role, he oversees the medical and scientific activities of the company. Langdon is responsible for directing clinical research and innovation in the development of new treatments. His medical expertise is essential to ensure that the company's products meet safety and efficacy standards.
